Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class small molecule product candidates with broad potential benefit to patients
Science
Modulating validated and new pathways to develop novel therapeutics
News
August 15,
2022
Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update
July 7,
2022
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference
June 9,
2022
Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
Events
Wednesday,
June 8TH,
2022
at
10:30 AM
Eastern
Jefferies Healthcare Conference
Listen: Webcast
Sunday,
June 5TH,
2022
at
7:30 AM
Eastern
Tempest Investor Breakfast at 2022 ASCO Annual Meeting
Listen: Webcast
Download: Tempest Investor Breakfast at 2022 ASCO Annual Meeting Presentation [pdf]
Monday,
March 29TH,
2021
at
8:30 AM
Eastern
Tempest and Millendo Proposed Merger Investor Call
Listen: Webcast
Download: Proposed Merger of Tempest and Millendo [pdf]